RPRX Royalty Pharma Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
01:25
Jan 23
Jan 23
Loves Royalty Pharma's biotech funding model.
Cramer loves Royalty Pharma's business model of helping fund biotech and earning returns, says the stock just keeps going higher and calls it a terrific company.
HIGH
01:01
Jan 23
Jan 23
Royalty Pharma's biopharma funding model works
Royalty Pharma keeps going higher; Cramer loves its step-function business model of funding biopharma and earning returns, and he has liked the company since its IPO.
MED
About RPRX Investor Commentary
Across the available history and selected sources, Buzzberg tracks RPRX (Royalty Pharma) across 1 sources: 2 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 2 total trade ideas tracked. Latest voices: Jim Cramer.